CliffBio
small molecule

CORGARD

NADOLOL

Loss of exclusivity—loss of exclusivity
CompanyUSWM, LLC →See this company's full patent-cliff portfolio

Drug detail

Brand nameCORGARD
Active ingredientNADOLOL
Strength120MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from USWM, LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CORGARD patent cliff — loss of exclusivity — | CliffBio